Skip to contentC
China Pharma Holdings, Inc.
C
CPHIChina Pharma Holdings, Inc. Q1 2019 · 10-Q
Revenue$2.93M$2.93M−19.0% vs Q1 2018 Net Income-$417.73K-$417.73KN/M vs Q1 2018 EPS Diluted-$0.01-$0.01N/M vs Q1 2018 Gross Profit$656,530−37.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
China Pharma Holdings, Inc. · CIK 1106644 · Engraved from SEC EDGAR
Operating Cash Flow$90,523−82.7% Free Cash Flowderived$16,657−96.8% Margins · derivedGross margin22.4%−6.7 pt vs Q1 2018
Operating margin-11.4%−7.5 pt vs Q1 2018
Net margin-14.3%−6.1 pt vs Q1 2018
ended Mar 31, 2019 · filed May 14, 2019 · 44 d after period end